Article
The impact of CYP2C19 polymorphism on platelet reactivity for guiding clopidogrel treatment and cost analysis
2013-04-01
Abstract excerpt
There has been a weak recommendation for routine genetic and Platelet function testing by the American college of cardiologists (ACC) for patients receiving clopidogrel. To investigate the variability in PFT response to CYP2C19 polymorphism and conduct a cost analysis. Eighty six Saudi patients who were stable on 75 mg clopidogrel at least for one month for various cardiac indications were enrolled. Genotyping by...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ad962b49-e0f7-56f0-a1c6-cfb83d2bfb94
- DOI
- 10.1016/j.jsha.2013.03.005
